Amicogen Inc. | Ownership
Companies that own Amicogen Inc.
Mirae Asset Global Investments Co., Ltd.
1,401,590
7.3%
-249,282
0.45%
03/30/2018
National Pension Service of Korea
758,194
3.95%
-186,802
0.02%
05/30/2017
The Vanguard Group, Inc.
397,604
2.06%
208
0%
07/31/2018
BlackRock Advisors (UK) Ltd.
227,715
1.19%
0
0%
09/06/2018
Norges Bank Investment Management
33,214
0.17%
33,214
0%
12/31/2017
Charles Schwab Investment Management, Inc.
19,604
0.1%
0
0%
09/06/2018
BlackRock Fund Advisors
18,559
0.1%
0
0%
09/05/2018
SSgA Funds Management, Inc.
13,432
0.07%
0
0%
09/06/2018
TIAA-CREF Investment Management LLC
8,876
0.05%
0
0%
03/31/2018
State Street Global Advisors Ltd.
2,648
0.01%
0
0%
09/05/2018
| Address |
64 Dongbu-ro 1259 beon-gil
Jinju SG 52621
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.amicogen.com |
| Updated |
09/14/2018 |
| Amicogen, Inc. engages in the development and marketing of enzyme products and functional food materials. Its products include specialty enzyme for pharmaceutical, food, feed and industrial; new bio-ingredient such as natural health ingredients for food, feed and cosmetics, finished products; and immunological products such as protein A resin, anticancer treatment vaccine based on B cell and mononuclear cell, and POCT immune diagnosis device using innovative C-ECL technology. It also engages in original equipment manufacturing and original development manufacturing of nutraceutical products. |
